Harmony Biosciences Holdings (HRMY) earnings · P/E 12, rev $868.5M
These earnings events as JSON? API free 100/dayHarmony Biosciences Holdings (HRMY) is a biotechnology company listed on NASDAQ.
This HRMY earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported HRMY revenue for 2025-12-31 was $868.5M. Net income was $158.7M. Revenue was up 21.5% from 2024-12-31 to 2025-12-31. HRMY currently screens at market cap $1.96B and trailing P/E 12.3.
When the next HRMY 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 21.5% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full HRMY research stays on the stock page; the tape stays on the quote page.
HRMY earnings FAQ
What are HRMY's latest revenue and net income?
Latest cached Harmony Biosciences Holdings (HRMY) revenue for Dec 31, 2025 was $868.5M. Net income was $158.7M. Statements: https://lician.com/financials/hrmy
What is HRMY's latest diluted EPS?
Latest cached Harmony Biosciences Holdings (HRMY) diluted EPS for Dec 31, 2025 was $2.71.
What period does the latest HRMY earnings print cover?
The latest cached Harmony Biosciences Holdings (HRMY) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did HRMY revenue change from the prior cached period?
Cached Harmony Biosciences Holdings (HRMY) revenue was up 21.5% from $714.7M (Dec 31, 2024) to $868.5M (Dec 31, 2025). Statements: https://lician.com/financials/hrmy
What is HRMY's P/E ratio?
Harmony Biosciences Holdings (HRMY) trailing P/E is 12.3 on the latest cached fundamentals snapshot.
Where are HRMY earnings listed?
Cached earnings facts for Harmony Biosciences Holdings (HRMY) are listed at https://lician.com/earnings/hrmy. Statements: https://lician.com/financials/hrmy
Not investment advice.